Thank Food And Drug Administration for Approving Generic Version of Cancer-Fighting Drug

Target: Margaret Hamburg, Commissioner of the Food and Drug Administration

Goal: Thank the Food and Drug Administration for approving generic version of a cancer-fighting drug

The United States Food and Drug Administration recently approved a generic version of the drug Doxil, which is commonly used to treat ovarian cancer, the AIDS-related illness Kaposi’s sarcoma, and the disease multiple myeloma.

This decision comes on the heels of a November 2011 issue with a Doxil manufacturer, which halted its operations due to a quality control problem. This created a shortage of Doxil which had become a serious health issue over the last few months. The FDA’s decision to approve a generic version of the drug will likely save many lives that would have been affected by the lack of the drug in circulation. The FDA should be commended for its decision.

The manufacturer in question, Ben Venue Laboratories, Inc. in Bedford, Ohio, was accused of operating with inadequately maintained equipment and allowing loose particles to invade injectable drugs. The FDA also deserves praise for discovering these transgressions and halting the manufacturing company before it could release any possibly contaminated or poorly prepared drugs to the public.

Recently, President Obama decreed that national drug shortages were a problem of the highest priority, and that they represented a serious challenge to national public health. The FDA has begun to do their part to eliminate the shortages and keep the public healthy. The generic version of Doxil will likely save many people who are afflicted with disease, and bring inner peace to the many more who are worried about the health of their friends and loved ones who had previously been unable to acquire medication. Sign the petition below to praise the FDA for approving the circulation of this important medicine.

PETITION LETTER:

Dear Commissioner Hamburg,

Your organization has recently released a generic version of a drug for cancer patients that will make it much easier for them to access necessary medication during this time of drug shortages. This decision will save many lives and grant inner peace to many more. For this, your company deserves the utmost praise and respect.

President Obama recently announced that drug shortages were a national priority, and that they represented a serious threat to national public health. Decisions such as yours, to increase the availability of disease-fighting drugs, aid the public during these trying times. With continued action such as this, the drug shortages can soon become a thing of the past.

This is a commendable step forward you’ve taken in the battle against disease. Your organization needs to continue to do things such as these to help keep the public healthy and safe. At the moment, though, your organization definitely needs to be recognized by the rest of the country–you’ve done it quite a service with this decision.

Sincerely,

[Your Name Here]

Sign the Petition

  • Your email will not be published. By signing you accept the ForceChange terms of service and may receive updates on this and related petitions.

Facebook Comments

comments

One Comment

  1. The fight against cancer needs all the help it can get, and the FDA should be thanked for any help it provides in that area. Legitimizing another potential treatment plan for cancer falls under this category of things they should be thanked for.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Notify me of followup comments via e-mail. You can also subscribe without commenting.

Signatures

  • Stefano Serpico
  • William & Katrina Dresbach
  • Mary Ann Cassidy
  • Betty J. Van Wicklen
  • FilizSelman
  • Robert Ortiz
  • Jean Marie Naples
  • lorenz steininger
1 of 5123...5